Skip to content
Clinical Trials – home
Therapeutic area

General disorders and administration site conditions – page 2

  • 140 clinical trials
  • 57 recruiting
  • 120 conditions
  • 23 countries

Conditions in this area

120 conditions with trials, the busiest first

Clinical trials in General disorders and administration site conditions

140 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

140 clinical trials

Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Ketamine
  • Sponsor:Fondation Lenval Nice
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Antwerp University Hospital
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:[Al[18F]F]Fapi-74
  • Sponsor:UZ Leuven
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Daratumumab
  • Sponsor:Helse Bergen HF
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:Centre Hospitalier Universitaire De Saint Etienne
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Isoflurane
  • Sponsor:Hospital Universitario La Paz
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cefepime
  • Sponsor:Centre Hospitalier Universitaire De Nice
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Rifampicin
  • Sponsor:UZ Leuven
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:University Hospital Of Clermont-Ferrand
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rifabutin
  • Sponsor:Centre Hospitalier De Tourcoing

Cancer fatigue

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:METHYLPHENIDATE
  • Sponsor:Odense University Hospital

Substances studied in this area

The therapies tested most often in General disorders and administration site conditions trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.